Patent · US Active

N-containing heteroaryl derivatives as JAK3 kinase inhibitors

US8501735B2 · kind B2 · utility

4Cited by

0References

36Claims

0Family size

Assignee

Palau Pharma, S.A. · ES

Inventors

Carmen Almansa Rosales · Barcelona, ES
Jorge Salas Solana · Granollers, ES
Robert Soliva Soliva · Sant Feliu de Llobregat, ES
Sergio Rodriguez Escrich · Tarragona, ES
Maria Gonzalez · Pontevedra, ES

Key dates

Filing date	Oct 29, 2010
Grant date	Aug 6, 2013
Priority date	—
Expiry date	Oct 29, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.